Ariosa’s Harmony Prenatal Test to be Available in US and Canada
California based diagnostics company, Ariosa Diagnostics has revealed that its Harmony Prenatal Test will be distributed by Laboratory Corporation of America in the United States and Canada.
The company added that Harmony Prenatal Test will be available in more than a thousand patient service center and can be used to detect whether there are fetal trisomies in maternal blood.The test is conducted by analyzing free floating DNA fragments known as cell-free DNA (cfDNA) which enter the mother's bloodstream from the fetus.
"Ariosa Diagnostics is very excited to announce the official launch of the Harmony Prenatal Test and the agreement with LabCorp, which helps us deliver on the promise of bringing an affordable and accessible prenatal testing option to pregnant women and their physicians", Ariosa Diagnostics CEO, Ken Song said.
P FDA Considering Approval of Travada for Preventing HIV in Healthy People Non-oral Contraceptives Raise Blood Clot Risks in Women M